{"id":"https://genegraph.clinicalgenome.org/r/f3fd0083-5f38-4338-bb17-2ad694f6ad32v1.0","type":"EvidenceStrengthAssertion","dc:description":"*TCN2* was first reported in relation to autosomal recessive transcobalamin II deficiency and megaloblastic anemia in 1971 (Hakami et al., PMID:5096637). This condition is primarly characterized by megaloblastic anemia and often includes phenotypes such as neurologic deficits, neutropenia, pancytopenia, failure to thrive, and recurrent infections. TCN2 deficiency is often accompanied by elevations in methylmalonic acid levels and plasma homocysteine levels. One cohort study from Trakadis YJ, et al. of 30 patients with TCN2 deficiency demonstrated that 17% had agammaglobulinemia, low IgGs, or low T and B cell counts, and 8% had recurrent infections (PMID:24305960). At least 48 variants have been identified in association with TCN2 deficiency (Luo et al., PMID: 36035190). In this curation, 12 variants were scored including frameshift, nonsense, and splice site variants across 10 probands from 9 publications (PMIDs: 32841161, 33685478, 35866322, 36035190, 31666257, 20352340, 24305960, 30185401, 33023511). Heterozygous parents and siblings were unaffected. The mechanism of pathogenicity is loss of function. \n\nThis gene-disease association is also supported by the biochemical function of TCN2 (PMID: 7742531).TCN2 is a transport protein that binds vitamin B12 and facilitates its uptake via endocytosis. Phenotypes displayed by patients with TCN2 deficiency are driven by the inability of cells to use vitamin B12. Vitamin B12 and folate are crucial to DNA synthesis. A lack of vitamin B12 causes impaired cell synthesis and manifests with deficits in rapidly dividing cells. It also manifests with elevated methylmalonic acid and homocysteine levels. Phenotypes observed in probands with TCN2 deficiency are in line with deficits consistent with vitamin B12 deficiency including pancytopenia, megaloblastic anemia, and neurologic defects. Additionally, the gene-disease relationship is supported by knock out *TCN2* zebrafish (PMID: 34132337). *TCN2* (-/-) zebrafish displayed phenotypes such as developmental delay and elevated methylmalonic acid levels consistent with vitamin B12 insufficiency. In summary, there is definitive evidence to support this gene-disease relationship. This classification was approved by the SCID-CID GCEP (SOP version 9). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f3fd0083-5f38-4338-bb17-2ad694f6ad32","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c2336cc7-730e-4205-8b2b-f1e1acfbd1f3","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c2336cc7-730e-4205-8b2b-f1e1acfbd1f3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2025-08-21T14:49:10.886Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/c2336cc7-730e-4205-8b2b-f1e1acfbd1f3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2025-08-21T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2336cc7-730e-4205-8b2b-f1e1acfbd1f3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92c05419-5545-4413-8ddb-3cee0b42aaac_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d31fb30-4de0-4180-924c-c32026897ac5","type":"EvidenceLine","dc:description":"Downscored due to homozygosity. Variant has an allele frequency of 0.0003737 (441/1180028) based on the European (Non-Finnish) population. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d31fb30-4de0-4180-924c-c32026897ac5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20352340","allele":{"id":"https://genegraph.clinicalgenome.org/r/11cf241e-4ee7-4459-9b08-5624f2b023b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.497_498del (p.Leu166ProfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10184679"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/92c05419-5545-4413-8ddb-3cee0b42aaac","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20352340","rdfs:label":"Schiff et al. Patient 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/11cf241e-4ee7-4459-9b08-5624f2b023b7"},"firstTestingMethod":"PCR","phenotypeFreeText":"Neutrophil count 0.94 ×10^9/L, Serum B12 (pM) 60 (155–670 pM), methylmalonic acid excretion 410 (NV<25), total homocysteine 46 (NV 5-15). Daily OHCbl IM (1 mg/day) resulted in stabilization of visual and cognitive functions.","phenotypes":["obo:HP_0001508","obo:HP_0002028","obo:HP_0001889"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1d31fb30-4de0-4180-924c-c32026897ac5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/362c60f3-90fd-444d-8a48-5ae939b70613_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4db41f5-dd89-49dc-b33f-f6b84a382c79","type":"EvidenceLine","dc:description":"Variant absent from gnomad. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4db41f5-dd89-49dc-b33f-f6b84a382c79_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33023511","allele":{"id":"https://genegraph.clinicalgenome.org/r/2de94056-af83-45de-b883-bde76ef34ca9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.1017_1031delinsGTAACAGAGATGGTT (p.Leu340Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695230573"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e75138ec-2743-40f9-879f-8d2fa5c68716","type":"EvidenceLine","dc:description":"Groupmax filtering allele freq in gnomad 4.0 of 0.000007380 based upon the East asian population. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e75138ec-2743-40f9-879f-8d2fa5c68716_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33023511","allele":{"id":"https://genegraph.clinicalgenome.org/r/e5dc397f-6450-43e1-9265-3af29325ee7e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.1033C>T (p.Gln345Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10184937"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/362c60f3-90fd-444d-8a48-5ae939b70613","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33023511","rdfs:label":"Zhan et al. Proband","allele":[{"id":"https://genegraph.clinicalgenome.org/r/2de94056-af83-45de-b883-bde76ef34ca9"},{"id":"https://genegraph.clinicalgenome.org/r/e5dc397f-6450-43e1-9265-3af29325ee7e"}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"red blood cell volume distribution width (RDW) of 24.6%, Immunologic phenotypes: high CD3 + cells 93.8% (reference: 39.0%-73.0%) and low CD3-CD(16 + 56) + cells 0.4% (reference: 3.0%-16.0%) and low CD3-CD19 + cells 4.9% (reference: 7.0%-41.0%). Low levels of globulin in the blood, with 0.05 g/L immunoglobulin IgA (reference: 0.13–0.35 g/L), 0.46 g/L IgG (reference: 3.22–7.18 g/L), and 0.04 g/L IgM (reference: 0.23–0.91 g/L). Respiratory failure occurred on day 98, and she required tracheal intubation with ventilator-assisted ventilation.\n\n","phenotypes":["obo:HP_0002090","obo:HP_0001876","obo:HP_0001972"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b4db41f5-dd89-49dc-b33f-f6b84a382c79_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e75138ec-2743-40f9-879f-8d2fa5c68716_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/ce6fb2a8-9332-4d32-8655-ab14dc70a263_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4651977b-cd31-4cfd-8e70-f7744194d15d","type":"EvidenceLine","dc:description":"Variant has an allele frequency of 0.000008993 (10/1111998) based on the European (Non-Finnish) population. Downscored due to family consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4651977b-cd31-4cfd-8e70-f7744194d15d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31666257","allele":{"id":"https://genegraph.clinicalgenome.org/r/44ef0102-004b-4fbc-8c48-3dbbdd95d465","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.1195C>T (p.Arg399Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10185016"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ce6fb2a8-9332-4d32-8655-ab14dc70a263","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31666257","rdfs:label":"Khera et al. Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/44ef0102-004b-4fbc-8c48-3dbbdd95d465"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Haemoglobin (Hb): 54 g/L (107–171), Total Leucocyte Count (TLC): 8.5×109/L (5–19.5) with absolute neutrophil count of 3.3×109/L (1.5–8.5), platelet count: 137×109/L (150–400), Mean Corpuscular Volume (MCV): 108 fL (91–112) and Mean Corpuscular Hb (MCH): 33 pg/cells (27–36). Serum vitamin B12 levels were 580 pmol/L (147–664), serum folate levels were 41.36 nmol/L (11.3–47.6), urinary spot MMA (qualitative) was elevated and plasma homocystine levels were 29.45 µmol/L (3.7–13.90). Dramatic response to parenteral cobalamin therapy - now asymptomatic. ","phenotypes":["obo:HP_0001889","obo:HP_0002028","obo:HP_0001508"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4651977b-cd31-4cfd-8e70-f7744194d15d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b45baa31-eb7e-4c43-9845-b96a72fffe90_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa115dc3-1879-4b3c-80a8-afb7808c6dc5","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa115dc3-1879-4b3c-80a8-afb7808c6dc5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36035190","allele":{"id":"https://genegraph.clinicalgenome.org/r/71262ce0-ca97-4cc4-a69c-b9a9b7eddfef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.1031_1032del (p.Arg344ThrfsTer20)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695230574"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d11dc326-191a-4e83-91ce-3e02e5e04dd7","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Splice AI and Pangolin predict that the variant may impact splicing with scores of 0.88 and 0.98 respectively.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d11dc326-191a-4e83-91ce-3e02e5e04dd7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36035190","allele":{"id":"https://genegraph.clinicalgenome.org/r/5cb2e0bd-d806-4b4e-8cb7-d2a4493f21db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.754-12C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695230571"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b45baa31-eb7e-4c43-9845-b96a72fffe90","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36035190","rdfs:label":"Luo et al. Proband","ageUnit":"Months","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5cb2e0bd-d806-4b4e-8cb7-d2a4493f21db"},{"id":"https://genegraph.clinicalgenome.org/r/71262ce0-ca97-4cc4-a69c-b9a9b7eddfef"}],"detectionMethod":"WES validated by Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Marasmus, Red Blood Cell Count (RBC) 2.25×1012/L (3.2–4.9), Hemoglobin (Hb) 73 g/L (90–140), White Blood Cell Count (WBC) 2.48×109/L (5.0–12), platelets count 3×109/L (100–378). Elevated urine methylmalonic acid level (23.87 μmol/L [0.2–3.6]) and an increased plasma homocysteine level (21.85 umol/l [<15]). The patient’s serum VB12 and folate levels were 275.60 pmol/L (139.4–651.5) and 17.86 nmol/L (7.0–46.4), respectively.","phenotypes":["obo:HP_0001876","obo:HP_0001942","obo:HP_0001508"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/fa115dc3-1879-4b3c-80a8-afb7808c6dc5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d11dc326-191a-4e83-91ce-3e02e5e04dd7_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/492a92c1-887a-4cb8-aa6f-4a2445448b6c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e45b237-d737-47e0-a540-02bc4566bba4","type":"EvidenceLine","dc:description":"Absent from gnomAD. Downscored due to consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e45b237-d737-47e0-a540-02bc4566bba4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24305960","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a6c8467-edf1-422f-8550-3b0f668dc737","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.1013_1014delinsTAA (p.Ser338IlefsTer27)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695230572"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/492a92c1-887a-4cb8-aa6f-4a2445448b6c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24305960","rdfs:label":"Patient 24 Trakadis et al. ","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a6c8467-edf1-422f-8550-3b0f668dc737"},"phenotypeFreeText":"At 3 month FTT, diarrhoea, generalized hypotonia, pancytopenia, developmental delay, low IgGs, low T and B cell counts; progressively transfusion, dependent NG feeds, lactose, opportunistic infections, intubated, myelodysplastic syndrome suspected","phenotypes":["obo:HP_0001889","obo:HP_0005403","obo:HP_0010976"],"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3e45b237-d737-47e0-a540-02bc4566bba4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/33701efe-6028-4f59-909f-13e4ebcbc0ec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ea5303c-7118-49bb-9491-5964c029b5e9","type":"EvidenceLine","dc:description":"Variant is absent from gnomad, downscored due to consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ea5303c-7118-49bb-9491-5964c029b5e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30185401","allele":{"id":"https://genegraph.clinicalgenome.org/r/0756afc6-2b9d-4fc8-a4de-eab822af467a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000022.11:g.30616117_30618259delinsCTGG","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2850455264"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/33701efe-6028-4f59-909f-13e4ebcbc0ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30185401","rdfs:label":"Unal et al. Case 1 ","allele":{"id":"https://genegraph.clinicalgenome.org/r/0756afc6-2b9d-4fc8-a4de-eab822af467a"},"phenotypeFreeText":"CMV viremia, cytopenia in peripheral blood, elevated ferritin, triglyceride and liver enzymes, and hemophagocytosis in the bone marrow. The patient’s serum vitamin B12 level was normal; however, the serum homocysteine level (23 µmol/L) was significantly higher than normal. Immunological phenotypes: lymphocyte subsets were in the normal ranges but at 2 months significantly low IgG 212 (376-685), IgA 26 (9-30), IgM (36-77), IGE <17. ","phenotypes":["obo:HP_0012735","obo:HP_0001744","obo:HP_0001889","obo:HP_0002014","obo:HP_0001945"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7ea5303c-7118-49bb-9491-5964c029b5e9_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f1b00327-4731-41ea-a418-7a48fd592de7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b319a369-5d2a-421d-b303-fb703e28bef5","type":"EvidenceLine","dc:description":"Predicted to cause skipping of exon 4. Downscored due to consanguinity. Variant is found at a rate of 0.00002669 (2/74932) in the African/African American population. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b319a369-5d2a-421d-b303-fb703e28bef5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20352340","allele":{"id":"https://genegraph.clinicalgenome.org/r/f58bb8b8-7948-432c-82fb-2cf8d02c1da4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.580+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411211103"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f1b00327-4731-41ea-a418-7a48fd592de7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20352340","rdfs:label":"Schiff et al. Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/f58bb8b8-7948-432c-82fb-2cf8d02c1da4"},"firstTestingMethod":"PCR","phenotypeFreeText":"Acute gastroenteritis, recurrent diarrhea, Hb 6 (g/dl)/MCV 95 (fl), Neutrophil count 0.63, methylmalonic acid excretion 590 mmol/mol creatinine, plasma methionine 30, plasma homocysteine  38","phenotypes":"obo:HP_0001889","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b319a369-5d2a-421d-b303-fb703e28bef5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0bb70345-a16e-4536-87b4-78f7d204a9c5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0184e13c-a72d-4607-8460-57b11917e81d","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Downscored due to potential consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0184e13c-a72d-4607-8460-57b11917e81d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35866322","allele":{"id":"https://genegraph.clinicalgenome.org/r/9fbbdb16-795b-4f56-a24f-d3ca1a5b9dcb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.22_31del (p.Leu8TrpfsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695230710"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0bb70345-a16e-4536-87b4-78f7d204a9c5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35866322","rdfs:label":"Toret et al. Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/9fbbdb16-795b-4f56-a24f-d3ca1a5b9dcb"},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"White cell count was 1180/μL with an absolute neutrophil count of 120/μL, and the platelet count was 11 000/μL.. Hemoglobin was 5.1 g/dL. Serum homocysteine, vitamin B12, and folic aside levels were 35.5 µmol/L (normal range 6-15), 412 pg/mL (normal range 200-860), and 19.9 ng/mL (normal range 2.7-17), respectively. ","phenotypes":["obo:HP_0001889","obo:HP_0001876","obo:HP_0002090","obo:HP_0001508"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0184e13c-a72d-4607-8460-57b11917e81d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e8952839-0f5a-45b0-a3e6-c421eaf05e7e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c37d673-cb7c-4ca9-abcf-c6db511db959","type":"EvidenceLine","dc:description":"Downscored due to consanguinity. Variant has an allele frequency of \t0.00001471 (1/68000) in the European (Non-Finnish) population in gnomAD 4.0. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c37d673-cb7c-4ca9-abcf-c6db511db959_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33685478","allele":{"id":"https://genegraph.clinicalgenome.org/r/fa46220b-caa0-4915-a3f0-53c13d97154e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.1117_1118del (p.Gln373GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA752355199"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e8952839-0f5a-45b0-a3e6-c421eaf05e7e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33685478","rdfs:label":"Martino et al. Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":31,"allele":{"id":"https://genegraph.clinicalgenome.org/r/fa46220b-caa0-4915-a3f0-53c13d97154e"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Folate, cobalamin and total protein blood concentrations were normal (19.2 ng/mL, 1940 pg/mL and 6 g/dl respectively). Homocystinuria. At age 8: WBC 2750/μL.","phenotypes":["obo:HP_0002013","obo:HP_0001889","obo:HP_0001824","obo:HP_0001876","obo:HP_0002014"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3c37d673-cb7c-4ca9-abcf-c6db511db959_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ab7ba257-9934-47bc-9ee3-ce80c748ed50_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b711c936-e85e-4700-a68a-2d1f4c40c921","type":"EvidenceLine","dc:description":"Variant is absent from gnomAD. Proband had an affected twin with the same genotype and similar phenotypes. Downscored due to consanguinity. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b711c936-e85e-4700-a68a-2d1f4c40c921_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32841161","allele":{"id":"https://genegraph.clinicalgenome.org/r/50d37f35-30d3-494f-8e71-9fa2e15ad368","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000355.4(TCN2):c.241C>T (p.Gln81Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411206492"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ab7ba257-9934-47bc-9ee3-ce80c748ed50","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32841161","rdfs:label":"Kose et al. Case one","allele":{"id":"https://genegraph.clinicalgenome.org/r/50d37f35-30d3-494f-8e71-9fa2e15ad368"},"detectionMethod":"Sequencing was performed with MiSeq V2 chemistry on MiSeq instrument (Illumina, CA, USA).","phenotypeFreeText":"white blood cell count, 6.3 × 10^9/L; absolute neutrophil count, 0.85 × 10^9/L; hemoglobin level, 7.2 g/dL; platelet count, 156 × 10^9/L, Vitamin B12 777 (200–900), Homocysteine 44.8 (μmol/L) (5–15), Urine methylmalonic acid (μmol/L) 756.4 (<3.6)","phenotypes":["obo:HP_0001510","obo:HP_0004315","obo:HP_0002098","obo:HP_0001889","obo:HP_0002014","obo:HP_0001508","obo:HP_0001875","obo:HP_0001252"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b711c936-e85e-4700-a68a-2d1f4c40c921_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/c2336cc7-730e-4205-8b2b-f1e1acfbd1f3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2336cc7-730e-4205-8b2b-f1e1acfbd1f3_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74bb23a3-40fe-4afe-a27a-b1061fcbbec2","type":"EvidenceLine","dc:description":"Downscored due to incomplete recapitulation between probands with TCN2 deficiency and KO TCN2 zebrafish. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a75931b-121c-4538-b947-2222ca6cf480","type":"Finding","dc:description":"Both the TCN2 knock out zebrafish model and probands with TCN2 deficiency displayed phenotypes such as developmental delay and elevated methylmalonic acid levels consistent with vitamin B12 insufficiency. However, due to significant physiologic differences, many phenotypes such as pancytopenia could not be accurately reproduced. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34132337","rdfs:label":"Knock out TCN2 Zebrafish","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c2336cc7-730e-4205-8b2b-f1e1acfbd1f3_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3638bb1a-6b01-49a5-a67c-44d6de34bd8a","type":"EvidenceLine","dc:description":"Upscored to 2 points given the very well characterized nature of vitamin B12 deficiency, the role of TCN2 as an uptake receptor of vitamin B12, and the similarities in phenotypes between vitamin B12 deficiency and TCN2 deficiency. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9323d1ad-e51b-408a-ac2c-10091ae17f52","type":"Finding","dc:description":"TCN2 binds vitamin B12 and transports vitamin B12 into the cell. Vitamin B12 deficiency classically results in megaloblastic anemia and is accompanied by increases in methyl malonic acid and homocysteine. Vitamin B12 and folate are crucial to steps involved in DNA synthesis. A lack of vitamin B12 causes impaired cell synthesis and manifests most often in rapidly dividing cells. Phenotypes in probands with TCN2 deficiency are in line with deficits consistent with vitamin B12 deficiency including pancytopenia, megaloblastic anemia, and neurologic deficits, as vitamin B12 is involved in the synthesis of myelin.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7742531","rdfs:label":"Biochemical function of TCN2","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Definitive","sequence":11343,"specifiedBy":"GeneValidityCriteria9","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/66plA8YpEio","type":"GeneValidityProposition","disease":"obo:MONDO_0010149","gene":"hgnc:11653","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c2336cc7-730e-4205-8b2b-f1e1acfbd1f3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}